Symptoms of chronic bronchitis, haemostatic factors, and coronary heart disease risk

Atherosclerosis

Volumn 142, Issue 2, 1999, Pages 403-407

  Jousilahti, Pekka ^a   Salomaa, Veikko ^a   Rasi, Vesa ^b   Vahtera, Elina ^b  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b FINNISH RED CROSS BLOOD SERVICE   (Finland)

Author keywords

Chronic bronchitis; Coronary heart disease; Fibrinogen; Haemostatic factors

Indexed keywords

BLOOD CLOTTING FACTOR 7; FIBRINOGEN; PLASMINOGEN;

ADULT; ARTICLE; BLOOD CLOTTING; CHRONIC BRONCHITIS; CORONARY ARTERY DISEASE; CORONARY RISK; FEMALE; FIBRINOGEN BLOOD LEVEL; HEMOSTASIS; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

EID: 0032932239     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00248-2     Document Type: Article

References (18)

1. Saikku P., Leinonen M., Mattila K. et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet. ii:1988;983-986.
2. Thom D.H., Wang S.-P., Grayston J.T. et al. Chlamydia pneumonia strain TWAR antibody and angiographically demonstrated coronary artery disease. Arterioscler. Thromb. 11:1991;547-551.
3. Mattila K.J., Nieminen M.S., Valtonen V.V. et al. Association between dental health and acute myocardial infarction. Br. Med. J. 298:1989;779-781.
4. Jousilahti P., Vartiainen E., Tuomilehto J., Puska P. Symptoms of chronic bronchitis and the risk of coronary disease. Lancet. 348:1996;567-572.
5. Danesh J., Collins R., Peto R. Chronic infections and coronary heart disease: is there a link? Lancet. 350:1997;430-436.
6. Meade T.W., Brozovic M., Chakrabarti R.R. et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park heart study. Lancet. 2(8506):1986;533-537.
7. Hamsten A. The hemostatic system and coronary heart disease. Thromb. Res. 70:1993;1-38.
8. Khaw K.-T., Woodhouse P. Interrelation of vitamin C, infection, haemostatic factors, and cardiovascular disease. Br. Med. J. 310:1995;1559-1563.
9. Folsom A.R., Wu K.K., Davis C.E., Conlan M.G., Sorlie P.D., Szklo M. Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis. 91:1991;191-205.
10. Wilson T.W., Kaplan G.A., Kauhanen J. et al. Association between plasma fibrinogen concentration and five socio-economic indices in the Kuopio Ischemic heart disease risk factor study. Am. J. Epidemiol. 137:1993;292-300.
11. Salomaa V., Rasi V.P., Vahtera E.M. et al. Haemostatic factors and lipoprotein (a) in three geographical areas in Finland: the finrisk heamostasis study. J. Cardiovasc. Risk. 1:1994;241-248.
12. Rose G.A., Blackburn H. Cardiovascular Survey Methods. 1968;World Health Organization, Geneva.
13. Sammalkorpi K. Glucose intolerance and acute infections. J. Int. Med. 225:1989;15-19.
14. Sammalkorpi K., Valtonen V., Kerttula Y., Nikkilä E., Taskinen M.-R. Changes in serum lipoprotein pattern induced by acute infection. Metabolism. 37:1988;859-865.
15. Nieto F.J., Sorlie P., Comstock G.W. et al. Cytomegalovirus infection, lipoprotein(a), and hypercoagulability: an atherogenic link. Arterioscler. Thromb. Vasc. Biol. 17:1997;1780-1785.
16. Meade T.W. Fibrinogen and cardiovascular disease. J. Clin. Pathol. 50:1997;13-15.
17. Woodhouse P.R., Khaw K.T., Plummer M., Foley A., Meade T.W. Seasonal variation of plasma fibrinogen and factor VII activity in the elderly: winter infections and death from cardiovascular disease. Lancet. 343:1994;435-439.
18. Peters A., Doring A., Wichmann H.E., Koenig W. Increased plasma viscosity during an air pollution episode: a link to mortality. Lancet. 349:1997;1582-1587.